272 related articles for article (PubMed ID: 29692608)
1. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
[TBL] [Abstract][Full Text] [Related]
2. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
Kong YJ; Sun WX; Zhang YM; Shi YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
[TBL] [Abstract][Full Text] [Related]
3. Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model.
Sun J; Bao J; Shi Y; Zhang B; Yuan L; Li J; Zhang L; Sun M; Zhang L; Sun W
Int J Chron Obstruct Pulmon Dis; 2017; 12():717-724. PubMed ID: 28260878
[TBL] [Abstract][Full Text] [Related]
4. ADAM15 expression is increased in lung CD8
Wang X; Zhang D; Higham A; Wolosianka S; Gai X; Zhou L; Petersen H; Pinto-Plata V; Divo M; Silverman EK; Celli B; Singh D; Sun Y; Owen CA
Respir Res; 2020 Jul; 21(1):188. PubMed ID: 32677970
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
7. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
[TBL] [Abstract][Full Text] [Related]
8. Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1.
Shen DD; Yang ZH; Huang J; Yang F; Lin ZW; Ou YF; Hu MH
Pharm Biol; 2019 Dec; 57(1):744-752. PubMed ID: 31679431
[No Abstract] [Full Text] [Related]
9. [Airway inflammation and macrophage inflammatory protein-1alpha, gelatinase B level in patients with COPD].
Cai S; Chen P; Zhu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jul; 24(7):429-32. PubMed ID: 11803002
[TBL] [Abstract][Full Text] [Related]
10. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
Kang MJ; Oh YM; Lee JC; Kim DG; Park MJ; Lee MG; Hyun IG; Han SK; Shim YS; Jung KS
J Korean Med Sci; 2003 Dec; 18(6):821-7. PubMed ID: 14676438
[TBL] [Abstract][Full Text] [Related]
11. [Markers of airway remodeling in induced sputum from healthy smokers].
Avilés B; Belda J; Margarit G; Bellido-Casado J; Martínez-Brú C; Casan P
Arch Bronconeumol; 2006 May; 42(5):235-40. PubMed ID: 16740239
[TBL] [Abstract][Full Text] [Related]
12. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma.
Chaudhuri R; McSharry C; Brady J; Grierson C; Messow CM; Spears M; Miele G; Nocka K; MacNee W; Connell M; Murchison JT; Sproule M; Hilmi OJ; Miller DK; Thomson NC
Eur Respir J; 2014 Oct; 44(4):895-904. PubMed ID: 24993912
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of correlation between pulmonary function and expression levels of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinase-1 among toluene diisocyanate exposed workers].
Miao PP; Meng T; Jia Q; Niu Y; Ye M; Ji YQ; Ju R; Chen XL; Shao H; Zheng YX; Dai YF
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):418-22. PubMed ID: 27141897
[TBL] [Abstract][Full Text] [Related]
14. Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV
Chung FT; Huang HY; Lo CY; Huang YC; Lin CW; He CC; He JR; Sheng TF; Wang CH
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31547356
[TBL] [Abstract][Full Text] [Related]
15. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
16. Activity of matrix metalloproteinase in airway epithelial cells of COPD patients.
Li W; Xu Y; Zhang Z
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):151-4. PubMed ID: 16116959
[TBL] [Abstract][Full Text] [Related]
17. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
18. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10.
Lim S; Roche N; Oliver BG; Mattos W; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1355-60. PubMed ID: 11029344
[TBL] [Abstract][Full Text] [Related]
19. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
[TBL] [Abstract][Full Text] [Related]
20. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
